AcelRx's DSUVIA Was Just Approved And The Stock Is Primed For A Sharp Upward Move [Seeking Alpha]
AcelRx Pharmaceuticals, Inc. (ACRX)
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acelrx.com/investor-relations
Company Research
Source: Seeking Alpha
AcelRx's DSUVIA Was Just Approved And The Stock Is Primed For A Sharp Upward MoveSummaryLast Friday, November 2, 2018, AcelRx Pharmaceuticals announced the FDA’s approval of its lead drug, DSUVIA, for use in the United States.This recent regulatory approval has eliminated nearly all near-term investment risk in the company and the stock could be set for sharp moves upward.A Licensing Agreement with a European partner to commercialize the product in the EU would provide the capital necessary to exploit the massive U.S. market opportunity for DSUVIA.
Show less
Read more
Impact Snapshot
Event Time:
ACRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRX alerts
High impacting AcelRx Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ACRX
News
- AcelRx Announces Rebranding With Name Change to Talphera, Inc. [Yahoo! Finance]Yahoo! Finance
- AcelRx Announces Rebranding With Name Change to Talphera, Inc.PR Newswire
- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
ACRX
Earnings
- 11/8/23 - Beat
ACRX
Sec Filings
- 1/9/24 - Form 8-K
- ACRX's page on the SEC website